Biofrontera (BFRI) Shares Outstanding (2020 - 2025)
Biofrontera's (BFRI) quarterly Shares Outstanding (Entity) came in at $11.6 million in Q4 2025, up 111.16% year-on-year from $5.5 million in Q4 2024, and little changed quarter-over-quarter from $11.6 million in Q3 2025.
Biofrontera (BFRI) Shares Outstanding (2020 - 2025) Analysis & Trends
Biofrontera's Shares Outstanding (Entity) history runs 6 years deep, the most recent figure standing at $11.6 million for Q4 2025.
- On a quarterly basis, Shares Outstanding (Entity) rose 111.16% year-over-year to $11.6 million in Q4 2025; TTM through Dec 2025 was $11.6 million, a 111.16% increase from a year earlier, with the FY2025 full-year figure at $11.6 million, up 111.16% from the prior year.
- Shares Outstanding (Entity) was little changed at $11.6 million in Q4 2025 per BFRI's latest filing, from $11.6 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $440.4 million in Q4 2021 and bottomed at $400000.0 in Q1 2021.
- The 5-year median for Shares Outstanding (Entity) is $1.4 million (2023), against an average of $25.7 million.
- Across the five-year window, Shares Outstanding (Entity) surged 38338.72% in 2021 and sank 99.76% in 2022, its largest moves.
- Year by year, Shares Outstanding (Entity) stood at $440.4 million in 2021, then sank by 99.76% to $1.1 million in 2022, then jumped by 43.58% to $1.5 million in 2023, then soared by 263.48% to $5.5 million in 2024, then jumped by 111.16% to $11.6 million in 2025.
- Per Business Quant, the three latest BFRI Shares Outstanding (Entity) figures stand at $11.6 million (Q4 2025), $11.6 million (Q3 2025), and $10.1 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 8.98 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1.16 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 422.10 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 43.50 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 455,871.00 |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 100.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 497.70 Mn |
| 10 | Biofrontera | 12.70 Mn | 6.29 Mn | 14.09 Mn | 10.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 10.17 Mn |
| Sep 30, 2025 | 10.78 Mn |
| Jun 30, 2025 | 9.35 Mn |
| Mar 31, 2025 | 8.87 Mn |
| Dec 31, 2024 | 5.52 Mn |
| Sep 30, 2024 | 5.77 Mn |
| Jun 30, 2024 | 5.09 Mn |
| Mar 31, 2024 | 3.62 Mn |
| Dec 31, 2023 | 1.55 Mn |
| Sep 30, 2023 | 1.37 Mn |
| Jun 30, 2023 | 1.36 Mn |
| Mar 31, 2023 | 1.33 Mn |
| Dec 31, 2022 | 1.06 Mn |
| Sep 30, 2022 | 1.14 Mn |
| Jun 30, 2022 | 941,175.00 |
| Mar 31, 2022 | 855,237.00 |
| Dec 31, 2021 | 440.41 Mn |
| Sep 30, 2021 | 400,000.00 |
| Jun 30, 2021 | 400,000.00 |
| Mar 31, 2021 | 400,000.00 |